USPTO 2015–2025 USPTO PatentsView US Corporation

Rtic IP, LLC

USPTO PatentsView assignee record - 58 granted patents across 0 technology areas, recorded in grant years 2018–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.

RSS updates for this company

The verdict

According to USPTO PatentsView, Rtic ranks #5,877 of 49,997 tracked US assignees by granted-patent volume, with 58 patents across 0 technology areas.

#5,877
of 49,997 US assignees by volume
3rd percentile
by Innovation Score (14.8/100)
1.0
avg claims per patent
-71%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5877 · US Corporation #5,877 · 58 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-UNK · INNOV-LOW · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-RICH

  • GRANTS-SMALL 58 grants
  • UPPER-Q #5,877/49,997
  • PHOTO-FINISH Prothena Biosciences
  • CPC-UNK CPC blank
  • INNOV-LOW 14.8/100
  • CLAIMS-SPARSE 1.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -71% vel
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Prothena Biosciences Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rtic’s 14.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Rtic

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Rtic's Innovation Score is 14.8/100 (3rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Rtic?

Each dot is one of Rtic’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rtic’s own 1.0 claims/patent is at or below the 9.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Rtic vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 57.958.058.05858.058.058.1 010203040 Granted patents (volume) Avg claims / patent Prothena Biosciences Limited - 58, 28.9Prothena Bioscien…Qizhi Software (BEIJING) Company Limited - 58, 3.36Qizhi Software (B…Rexon Industrial Corp., Ltd. - 58, 9.31Rexon IndustrialRiken Technos Corporation - 58, 11.38Riken TechnosRareCyte, Inc. - 58, 17.14RarecyteReal Value LLC - 58, 1.84Real ValueRiverpoint Medical, LLC - 58, 11.74Riverpoint MedicalSakata INX Corporation - 58, 7.48Sakata INXRtic IP, LLC - 58, 1Rtic IP
Rtic vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rtic's grants concentrate

Rtic IP, LLC is a focused PatentsView assignee: 0 CPC subclasses . Peak complete grant year is 2019 (37 grants) versus a trough of 1 in 2023. By volume, Rtic sits between Prothena Biosciences Limited and Sakata INX Corporation.

Rtic's three-year grant acceleration

From 2019–2021 to 2022–2024, Rtic IP, LLC moved from 49 to 1 grants (0.02x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Rtic's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Rtic holds 58 patents at rank #5,874, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Rtic

By rank, the assignees closest to #5,874 in granted patent volume.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Rtic, neither rank-band nor same-CPC leaders (those blocks stay above).

Rtic's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

15 3rd percentile higher than 3% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

010203040 2018201920202023 1
USPTO utility patent grants by year · 2018–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Rtic IP, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 8 13.8%
2019 37 63.8%
2020 12 20.7%
2023 1 1.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Rtic IP, LLC's patent record in context - here's where to go next.

  • Ranked #5,877 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Rtic IP, LLC against Prothena Biosciences Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 14.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.